Global Nerve Regeneration and Repair market is expected to reach USD 18.2 billion by 2024 from USD 7.5 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.
Global Nerve Regeneration and Repair Market, By Type (Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Neurostimalation (Internal (SCS, DBS, VNS, SNS, GES), External (TENS, TMS, RES))), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair (Epineural, Perineural, Group Fascicular Repair), Grafting (Autograft, Allograft, Xenograft)), By End-User (Hospitals, Neurology Clinics, Home Healthcare, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America, Rest of the World) – Trends and Forecast to 2024
The market is segmented based on product type, end-user and geography:
By Product Type:
Key Players operating in the APAC Nerve Regeneration and Repair Market:
· AxoGen Inc.
· Boston Scientific Corporation
· Medovent GmbH
· Baxter International
· Checkpoint Surgical Inc.
· St. Jude Medical, Inc.
· Integra Lifesciences Corporation
· Toyobo Co., Ltd.
· Nevro Corporation
· Orthomed S.A.S.
· Collagen Matrix, Inc.
· Cyberonics, Inc.
· Polyganics B.V.
· Stryker Corporation
Europe Internal Neuromodulation Devices Market – – Trends and Forecast to 2022
Office Number-317, Amanora Chambers,
Magarpatta Road, Hadapsar,